Predictors of Relapses or Recurrences in Patients With Giant Cell Arteritis: A Medical Records Review Study.

Source: J Clin Rheumatol 2023 Jan 23; . doi: 10.1097/RHU.0000000000001942Authors: Gomes de Pinho Q, Daumas A, Benyamine A, Bertolino J, Ebbo M, Schleinitz N, Harlé J-R, Jarrot P A, Kaplanski G, Berbis J, Boucekine M, Rossi P, Granel B

Giant cell arteritis (GCA) is the most common systemic vasculitis in individuals aged ≥50 years. Its course is marked by a high relapse rate requiring long-term glucocorticoid use with its inherent adverse effects. We aimed to identify factors associated with relapses or recurrences in GCA at diagnosis.

Pubmed ID: http://www.ncbi.nlm.nih.gov/pubmed/36727749?dopt=Abstract